Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA “Critical Path” Will Emphasize Clinical Trial Simulation For Drugs

Executive Summary

FDA's "Critical Path" initiative will encourage drug manufacturers to use computer modeling to improve clinical trial design, Acting Deputy Commissioner for Operations Janet Woodcock, MD, said

You may also be interested in...



Computer Simulations Of Clinical Trials To Be Addressed In FDA Guidance

FDA plans to address the use of computer simulation models in an upcoming guidance on issues firms should consider at the end of Phase IIa

Computer Simulations Of Clinical Trials To Be Addressed In FDA Guidance

FDA plans to address the use of computer simulation models in an upcoming guidance on issues firms should consider at the end of Phase IIa

FDA Will Publish “Critical Path” Opportunities List By Fall, Woodcock Says

FDA plans to finalize its list of "Critical Path" opportunities by early fall, Acting Deputy Commissioner for Operations Janet Woodcock said

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel